patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: patientman..hopefully, you'll receive a response from Craig Bird or Charlie

Glad you weren't put off by my post.  As I think you're aware, I'm just trying to generate more in depth discussion than the usual "this thing can't miss" or "this stock is garbage".  I'd love to hear some unbiast experts in this industry give their opinions and insight regarding Pluristem's technology.  I'm sure they're out there and possible read Agoracom.

Share
New Message
Please login to post a reply